← Open Payments lookup

ADAM CAREY: Open Payments

NPI 1750081535 · CUMBERLAND, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,139 in 101 payments from 18 companies in 2025. Trend: 2023 $750 · 2024 $2,077 · 2025 $2,139

Food & beverage: $2,139
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$509
GlaxoSmithKline, LLC.12$207
Aimmune Therapeutics, Inc.9$187
Exact Sciences Corporation9$181
ABBVIE INC.12$159
TOLMAR, INC.8$146
Novo Nordisk Inc6$145
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$102
Amgen Inc.4$100
Lilly USA, LLC3$85

Products named: AIRSUPRA, Cologuard Collection Kit, BREZTRI, TRELEGY ELLIPTA, JATENZO, FARXIGA, ZENPEP, QULIPTA.

Industry payments across RI — which companies pay providers there.